(RTTNews) - Ultragenyx Pharmaceutical Inc. (RARE) announced on Wednesday that it has agreed to sell a Rare Pediatric Disease Priority Review Voucher for $203 million.
Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.